Wong Hing C bought 113,879 derivative units of HCW Biologics Inc. at $0.00 for $0 on May 22, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Chief Executive Officer
Chief Executive Officer
Filed May 27, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
113,879Common Stock Purchase Warrant
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
118,110Direct
Trade date
May 22, 2026Buy
Filed
May 27, 2026, 7:26 PM ET5-day reporting delay
Accession
0001493152-26-025478Code P · Transaction 88111
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 22, 2026Buy113,879$1.41$160,000Trade 88110
2 transaction rows in this filing. Joint filers share the same rows.

HCWB price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
HCWB · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −80%1w ago −37%1d ago +33%
Returns since7d −13%30d −47%90d +30%180d1y

Footnotes in full

F1: The reporting person purchased these shares directly from the issuer in a private placement, which purchase is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended.